Early Versus Late Conversion from Prograf to Advagraf in Renal Transplant Patients

被引:0
|
作者
Falconer, S. J. [1 ]
Oniscu, G. C. [1 ]
机构
[1] Univ Edinburgh, Transplant Unit, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1097/00007890-201211271-01952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
1344
引用
收藏
页码:988 / 988
页数:1
相关论文
共 50 条
  • [41] Outcome of Conversion from Twice-Daily Tacrolimus (Prograf®) to Once-Daily Prolonged Release Tacrolimus (Advagraf®) in Stable Liver Transplant Recipients: University of Bologna Experience
    Del Gaudio, Massimo
    Cescon, Matteo
    Ercolani, Giorgio
    Cucchetti, Alessandro
    Zanello, Matteo
    Dazzi, Alessandro
    Lauro, Augusto
    Ravaioli, Matteo
    Tame, Maria Rosa
    Morelli, Cristina
    Pinna, Antonio Daniele
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S207 - S207
  • [42] TACROLIMUS ONCE DAILY (Advagraf) VERSUS TWICE DAILY (Prograf) IN LIVER TRANSPLANTED PATIENTS: AN OBSERVATIONAL SINGLE-CENTRE STUDY
    Utech, Wanda
    Di Maro, Orlandina
    Guardascione, Salvatore
    Lanza, Alfonso Galeota
    Picciotto, Francesco Paolo
    Di Costanzo, Giovan Giuseppe
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 181 - 181
  • [43] Population Pharmacokinetics of Tarolimus in Pediatric Renal Transplant Recipients on Two Different Formulations-Twice-daily Prograf® and Once-daily Advagraf®
    Yi, SoJeong
    Lim, Hyeong-Seok
    Yoon, Seonghae
    Moon, Seol Ju
    Min, Sang-il
    Ha, Jongwon
    Jang, In-Jin
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S52 - S52
  • [44] CONVERSION FROM PROGRAF TO ADVAGRAF IN ADOLESCENTS WITH NORMAL GRAFT FUNCTION AFTER LIVER TRANSPLANTATION: BIOEQUIVALENCE ON 1:1 DAILY DOSE
    Jara, Paloma
    Hierro, Loreto
    Pinana, Enrique
    Camarena, Carmen
    de la Vega, Angela
    Frauca, Esteban
    Munoz Bartolo, Gema
    Diaz, Carmen
    Hernandez, Francisco
    Leal, Nuria
    Murcia, Javier
    Gamez, Manuel
    Lopez Santamaria, Manuel
    Carcas, Antonio J.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S71 - S72
  • [45] Impact of the Conversion of the Immunsuppressive Regimen from Prograf to Advagraf or to Sirolimus in Long Term Stable Liver Transplant Recipients. Indications, Safety and Outcome. A Single Center Experience
    Perrakis, Aristotelis
    Schwarz, Kerstin
    Croner, Roland
    Schellerer, Vera
    Lohmueller, Clemens
    Mueller, Volker
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S249 - S249
  • [46] Bioequivalence of Generic Tacrolimus (Tacrobell®) to Prograf® in De Novo Renal Transplant Patients
    Min, S. -I.
    Park, D.
    Kim, S. M.
    Park, T.
    Ahn, S.
    Min, S. -K.
    Kim, S. J.
    Ha, J.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 249 - 249
  • [47] Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus)
    Van Buren, D
    Payne, J
    Geevarghese, S
    MacDonell, R
    Chapman, W
    Wright, JK
    Helderman, JH
    Richie, R
    Pinson, CW
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1401 - 1402
  • [48] Early Conversion to Everolimus in Renal Transplant Recipients
    Guditi, S.
    Rapur, R.
    Vasa, R.
    Sunder, S.
    Naidu, D.
    Dakshinamurty, K., V
    [J]. TRANSPLANTATION, 2012, 94 (10) : 97 - 97
  • [49] Early Versus Late Acute Antibody-Mediated Rejection in Renal Transplant Recipients
    Dorje, Christina
    Midtvedt, Karsten
    Holdaas, Hallvard
    Naper, Christian
    Strom, Erik H.
    Oyen, Ole
    Leivestad, Torbjorn
    Aronsen, Tommy
    Jenssen, Trond
    Flaa-Johnsen, Linda
    Lindahl, Jorn Petter
    Hartmann, Anders
    Reisaeter, Anna Varberg
    [J]. TRANSPLANTATION, 2013, 96 (01) : 79 - 84
  • [50] Design of a Simplified Medication Regimen in Renal Transplant Patients by Using Tacrolimus OD (ADVAGRAF®)
    Kerkhofs, C.
    van Boekel, G.
    Hilbrands, L.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 773 - 773